期刊文献+

肝癌合并门静脉癌栓治疗的研究进展 被引量:2

Treatment progress on hepatocellular carcinoma with portal vein tumor thrombus
下载PDF
导出
摘要 门静脉癌栓是进展期肝癌常见并发症之一,严重影响患者生活质量和预后。除传统手术治疗外,肝动脉栓塞化疗、局部消融、放射治疗、靶向药物、免疫治疗等联合应用可取得良好效果。根据不同类型门静脉癌栓,合理选择治疗方法尚未达成共识。该文综述了肝癌合并不同分型门静脉癌栓治疗的研究进展。 Portal vein tumor thrombus(PVTT)is one of common complications of advanced hepatocellular carcinoma(HCC)and seriously affects patient's quality of life and prognosis.Besides traditional surgery,combination of hepatic artery chemoembolization,local ablative therapy,radiotherapy,targeted drugs and immunotherapy can achieve satisfactory efficacies.According to different PVTT types,there is no consensus on the reasonable choice of treatment methods.This article reviews treatment progress on HCC with various PVTT types.
作者 覃夏 陈建发 QIN Xia;CHEN Jian-fa(Department of General Surgery,First Naval Hospital of Southern Command,Zhanjiang 524009,China)
出处 《广东医科大学学报》 2021年第4期505-510,共6页 Journal of Guangdong Medical University
关键词 肝细胞癌 门静脉癌栓 多学科治疗 hepatocellular carcinoma portal vein tumor thrombus multidisciplinary therapy
  • 相关文献

参考文献10

二级参考文献114

  • 1Jia Fan,Zhi Quan Wu,Zhao You Tang,Jian Zhou,Shuang Jian Qiu,Zeng Chen Ma,Xin Da Zhou,Sheng Long Ye Liver Cancer Institute, Zhongshan Hospital, Fudan University Medical Center (Former Shanghai University), 136 Yixueyuan Road, Shanghai 200032, China.Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein[J].World Journal of Gastroenterology,2001,7(1):28-32. 被引量:80
  • 2JiaFan JianZhou Zhi-QuanWu Shuang-JianQiu Xiao-YingWang Ying-HongShi Zhao-YouTang.Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis[J].World Journal of Gastroenterology,2005,11(8):1215-1219. 被引量:65
  • 3程树群,吴孟超,陈汉,沈锋,杨家和,丛文铭,赵玉祥,王培军,丁光辉.肝细胞癌伴门静脉癌栓不同治疗方法的疗效比较[J].中华肿瘤杂志,2005,27(3):183-185. 被引量:15
  • 4Masami Minagawa,Masatoshi Makuuchi.Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus[J].World Journal of Gastroenterology,2006,12(47):7561-7567. 被引量:78
  • 5Alexander J. Thompson,Andrew J. Muir,Mark S. Sulkowski,Dongliang Ge,Jacques Fellay,Kevin V. Shianna,Thomas Urban,Nezam H. Afdhal,Ira M. Jacobson,Rafael Esteban,Fred Poordad,Eric J. Lawitz,Jonathan McCone,Mitchell L. Shiffman,Greg W. Galler,William M. Lee,Robert Reindollar,John W. King,Paul Y. Kwo,Reem H. Ghalib,Bradley Freilich,Lisa M. Nyberg,Stefan Zeuzem,Thierry Poynard,David M. Vock,Karen S. Pieper,Keyur Patel,Hans L. Tillmann,Stephanie Noviello,Kenneth Koury,Lisa D. Pedicone,Clifford A. Brass,Janice K. Albrecht,David B. Goldstein,John G. McHutchison.Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus[J]. Gastroenterology . 2010 (1)
  • 6Josep M. Llovet,Jordi Bruix.Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J]. Hepatology . 2003 (2)
  • 7Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncology.2009(1)
  • 8Shukui Qin,Yuxian Bai,Ho Yeong Lim,Sumitra Thongprasert,Yee Chao,Jia Fan,Tsai-Shen Yang,Vajarabhongsa Bhudhisawasdi,Won Ki Kang,Yu Zhou,Jee Hyun Lee,Yan Sun.Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia[J].Journal of Clinical Oncology.2013(28)
  • 9Stephen L. Chan,Frankie K. F. Mo,Cesar S. C. Wong,Charles M. L. Chan,Linda K. S. Leung,Edwin P. Hui,Brigette B. Ma,Anthony T. C. Chan,Tony S. K. Mok,Winnie Yeo.A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma[J].Cancer.2011(16)
  • 10Josep Llovet,Concepció Brú,Jordi Bruix.Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification[J].Semin Liver Dis.1999(03)

共引文献733

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部